Business EconomyPosted at: Nov 12 2025 12:41AM


Granules Life Sciences gets first U.S. FDA approval for Hyderabad Facility

Hyderabad, Nov 11 (UNI) Granules India Limited, on Tuesday announced that its wholly owned subsidiary, Granules Life Sciences Private Limited (GLS), located here, has received U.S. Food and Drug Administration (FDA) approval for a product that was the subject of a Pre-Approval Inspection (PAI) conducted between July 28 and August 1.
There was one observation during that inspection, and the GLS had submitted its response within the stipulated time.
With this approval, the GLS facility is now deemed approved by the U.S. FDA, marking a major milestone for Granules India as it expands its finished dosage manufacturing capabilities. This is the first FDA approval for the GLS site, the Hyderabad pharma said in a release here.
The company plans to launch the approved product in the U.S. market soon. The same product is already approved and manufactured at Granules’ Gagillapur facility. The new approval will help strengthen market share and support business continuity through multi-site manufacturing.
“We plan on launching the product into the U.S. market soon. It is an already approved product at our Gagillapur facility, but we plan on building market share with this approval,” said Dr. Krishna Prasad Chigurupati, Chairman & Managing Director, Granules India Limited.
“We also have other products filed from this site and expect the U.S. FDA to approve them following necessary audits if required. This marks the first approval from our second Hyderabad facility with finished dosage capabilities,” he added.
UNI KNR SSP
Please log in to get detailed story.
Tags: #Granules Life Sciences gets first U.S. FDA approval for Hyderabad Facility
More News

India recorded 6X jump in production, 8X rise in exports over 11 years in electronics manufacturing: Jitin Prasada

05 Dec 2025 | 4:24 PM

New Delhi, Dec 5 (UNI) India has emerged as a major global hub for electronics manufacturing, recording a sixfold jump in overall production and an eightfold rise in exports over the past eleven years, said Jitin Prasada, union Minister of State for Electronics and Information Technology, in a response in the Rajya Sabha.

see more..

RBI policy repo rate reduction will strengthen India’s growth trajectory and domestic production: PHDCCI

05 Dec 2025 | 4:18 PM

New Delhi, Dec 5 (UNI) Appreciating the decision of the RBI Monetary Policy Committee to reduce the repo rate, President of PHDCCI Rajeev Juneja said that the decision will "support the growth momentum" in the economy.

see more..

RBI Governor emphasises need for banks, NBFCs to place customers at centre of operations

05 Dec 2025 | 4:07 PM

New Delhi, Dec 5 (UNI) The Reserve Bank of India (RBI) Governor Sanjay Malhotra, on Friday, while announcing the Monetary Policy Committee (MPC) decision, emphasised the need for banks and non-banking financial companies (NBFCs) to place customers at the centre of their operations.

see more..

Real estate sector hails RBI’s rate cut, expects it to raise housing demand

05 Dec 2025 | 3:26 PM

New Delhi, Dec 5 (UNI) The real-estate sector on Friday reacted with clear optimism to the Reserve Bank of India’s 25-basis-point repo rate cut, seeing it as a timely catalyst that could unlock fresh buying momentum and deepen investor participation at a time when demand remains structurally strong.

see more..

RBI cuts repo rate by 25 basis points to 5 25 percent

05 Dec 2025 | 3:10 PM

Mumbai, Dec 5 (UNI) The Reserve Bank of India (RBI) released its bi-monthly monetary policy here on Friday after the Monetary Policy Committee (MPC) concluded its three-day review process which began on Wednesday with an RBI panel led by RBI Governor Sanjay Malhotra unanimously voting to cut the government securities (G-Secs) repurchase (repo) rate by 25 basis points (bps) to 5.25 percent.

see more..